Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.19.3
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
USD ($)
$ / shares
shares
Sep. 30, 2018
USD ($)
$ / shares
shares
Sep. 30, 2019
USD ($)
$ / shares
shares
Sep. 30, 2018
USD ($)
$ / shares
shares
Revenues:        
Total revenues $ 947 $ 1,650 $ 2,394 $ 5,381
Operating expenses:        
Cost of goods sold 188 178 738 248
Research and development 1,619 1,910 5,370 5,623
Selling, general and administrative 3,023 1,514 9,336 4,508
Total operating expenses 4,830 3,602 15,444 10,379
Loss from operations (3,883) (1,952) (13,050) (4,998)
Other income (expense):        
Interest expense, net (238) (227) (737) (650)
Gain on debt extinguishment, net 291 0 226 0
Non-cash gain on changes in fair value 1,041 141 1,066 141
Other expense, net (14) (7) (22) (12)
Other income (expense), net 1,080 (93) 533 (521)
Net loss and comprehensive loss (2,803) (2,045) (12,517) (5,519)
Deemed dividend on trigger of down round provision 0 (285) 0 (285)
Net loss and comprehensive loss attributable to common stockholders $ (2,803) $ (2,330) $ (12,517) $ (5,804)
Basic net loss per share | $ / shares $ (0.18) $ (0.64) $ (0.89) $ (1.62)
Diluted net loss per share | $ / shares $ (0.18) $ (0.68) $ (0.89) $ (1.66)
Weighted-average shares for basic and diluted net loss per share | shares 15,517 3,650 14,112 3,573
License revenue        
Revenues:        
Total revenues $ 0 $ 1,406 $ 313 $ 5,063
Product revenue        
Revenues:        
Total revenues 190 244 811 318
Grant revenue        
Revenues:        
Total revenues $ 757 $ 0 $ 1,270 $ 0